Page 4 - Les meilleurs doctors traitant la maladie suivante : Cancer du poumon - TOP -140 des médecins

Dirige les essais cliniques sur le cancer du thorax à l'Hôpital Quiron Barcelona – Le professeur Felip est spécialisée dans le cancer du poumon avec plus de 900 interventions réalisées.

• 38 ans d'expérience en oncologie
• Innover dans les approches pharmacogénomiques et d'immunothérapie
• Être membre de la direction de l'ESMO, de l'ASCO et de l'IASLC
• Recevoir le prix ESMO Women for Oncology

Spécialisé en chirurgie thoracique mini-invasive et robotique à l'hôpital universitaire Ponderas – reconnu pour ses petites incisions et sa récupération rapide.

• Expert en chirurgie thoracique robotique avec le système da Vinci Xi
• Réaliser des chirurgies thoracoscopiques vidéo-assistées (VATS), y compris la VATS uniportale
• Compétent dans les résections pulmonaires et médiastinales complexes
• Proposer des procédures mini-invasives sans drainage pleural postopératoire

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Dr. Kurt Rasche is a German pulmonologist with more than 40 years of clinical experience. He is Chief of Pulmonology at Helios University Hospital Wuppertal. He leads the departments of pulmonology, sleep medicine, and ventilation therapy. He also heads the certified Lung Cancer Center.

He is certified in internal medicine, pulmonology, allergology, sleep medicine, and intensive care. His clinical work focuses on diagnosing and treating chronic lung diseases, lung cancer, and sleep-related breathing disorders. He works closely with specialists from other fields to provide coordinated care.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Amr Mahmoud Al Demery is a consultant thoracic surgical oncologist with 12 years of experience. He holds an M.B.B.Ch from Kasr El-Aini, Cairo University (2007). He earned a Master’s in Surgical Oncology in 2014 and a Doctorate in Surgical Oncology in 2019 from the National Cancer Institute, Cairo University. He is a Member of the Royal College of Surgeons of England (MRCS, 2014). He speaks English and Arabic.

His practice includes the assessment, diagnosis, and surgical treatment of thoracic cancers. He performs bronchoscopy, thoracoscopy, and mediastinoscopy. He carries out lung resections, including wedge resection, lobectomy, bilobectomy, and pneumonectomy. He also performs esophageal resection with reconstruction and pleural decortication. His work includes thymectomy and mediastinal lymph node dissection. He performs chest wall and diaphragmatic tumor resection with reconstruction.

He served as Resident, Assistant Lecturer, and Lecturer of Surgical Oncology at the National Cancer Institute, Cairo University. He is a consultant in thoracic surgical oncology at Dar El-Salam, Tanta, Damanhour, and Shefaa Al Orman Cancer Centers. He is a member of the Egyptian Society of Surgical Oncology. He is a cofounder and member of the Egyptian Society of Respiratory Neoplasms.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Le Dr Zalmanova est spécialisée en radiothérapie du cancer du poumon au centre médical Assuta.

• Radiothérapeute spécialisée dans le traitement du cancer du poumon
• Travaille au centre médical Assuta, un établissement de santé de premier plan
• Élaborer des plans de traitement personnalisés

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Le Pr Nir Peled dirige l'unité de cancérologie thoracique du centre médical Sheba et est le principal spécialiste israélien de l'immunothérapie du cancer du poumon.

• Expert en pneumologie, médecine interne et oncologie médicale
• Spécialisé dans la médecine personnalisée et les nouvelles technologies de diagnostic
• Titulaire du prestigieux prix ASCO MERIT pour la recherche clinique
• Président du comité de détection précoce et de prévention de l'IASLC
• Formation spécialisée à l'Université du Colorado à Denver

Le Dr Lo Zhunchen a plus de 20 ans d'expérience en médecine respiratoire et en hématologie clinique à l'hôpital de cancérologie Fuda.

• Se spécialiser en médecine interne, médecine respiratoire et hématologie clinique
• Être expérimenté dans les traitements de chimiothérapie et de radiothérapie
• Se concentrer sur le confort et la satisfaction des patients
• S'engager envers la médecine factuelle et l'éducation des patients

Spécialisé en oncologie chirurgicale thoracique avec une expertise en chirurgie thoracoscopique vidéo-assistée (VATS) pour le cancer du poumon au Medical Park Göztepe Hospital Complex.

• Formation spécialisée à l'Université de Paris-Sud, Hôpital Marie-Lannelongue
• Membre de la Société Européenne des Chirurgiens Thoraciques
• Publication de 13 articles dans des revues internationales
• Plus de 15 ans d'expérience en chirurgie thoracique